Multiple Sclerosis Treatment and Melanoma Development

Multiple Sclerosis Treatment and Melanoma Development

Therapy of multiple sclerosis (MS) with disease-modifying agents such as natalizumab or fingolimod has been associated with the development of cutaneous melanoma. Here we briefly revise literature data and report of a case of a 48-year old woman who developed a melanoma and several atypical naevi af...

Full description

Bibliographic Details
Main Authors: Maria Luigia Carbone, Pedro Miguel Lacal, Serena Messinese, Laura De Giglio, Carlo Pozzilli, Severino Persechino, Cinzia Mazzanti, Cristina Maria Failla, Gianluca Pagnanelli
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:International Journal of Molecular Sciences
Subjects:
melanoma
fingolimod
natalizumab
VEGF-A
Online Access:https://www.mdpi.com/1422-0067/21/8/2950

Internet

https://www.mdpi.com/1422-0067/21/8/2950

Similar Items